Search - tctmd.com

Displaying 541 - 560 of 790

Sort: Relevancy | Date

Presentation TVT 2016

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Presenter: Nicolas M. Van Mieghem

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

Presentation TVT 2016

Study Design for the PARTNER 3 Low-Risk Trial

Presenter: Martin B. Leon

June 16, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Updates From NOTION: The First All-Comer TAVR Trial

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Ganesh Manoharan

June 16, 2016

Presentation TVT 2016

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Azeem Latib

June 16, 2016

Presentation TVT 2016

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: James B. Hermiller Jr

June 16, 2016

Presentation TVT 2016

The SAPIEN 3 TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Susheel Kodali

June 16, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

Advertisement

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Study Design for the PARTNER 3 Low-Risk Trial

Study Design for the EVOLUT R Low-Risk Trial

Updates From NOTION: The First All-Comer TAVR Trial

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The SAPIEN 3 TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content